Evaluation of TNF-α and TNF-R1 immunomarkers in Renal Failure Patients in Karbala province
DOI:
https://doi.org/10.47577/biochemmed.v10i.11865Abstract
Renal failure is characterized by height level of pro-inflammatory cytokines, mainly Tumor necrosis factor-alpha (TNF-α) and its receptor TNF-R1. The aim was to investigate the association of TNF-α and TNF-R1 levels in Renal Failure.This study was carried out from February 2022 to March 2023 in the labs of Thi-Qar University's Col1ege of Education for Pure Sciences. In partnership with Al-Hussein Teaching Hospital, Nasiriyah General Hospital, and Thi-Qar Center for Nephrology and Dialysis in Thi-Qar Province .The study comprised (100) patients for both sex : (40 patients with diabetes mellitus), (40 patients without diabetes mellitus) whose serum urea level and serum creatinine level were examined, and (40 healthy).The level of biochemical indicators were measured, which included urea, creatinine, albumin and total protein where the study discovered a considerable rise in urea and creatinine levels compared to healthy subjects and standard rates, and this increase is related 'with a decrease GFR', while there is decrease in rate of albumin and total protein. The statistical analysis' findings revealed a considerable difference (p <0.05) in patients with RF in concentration of the TNF-α and TNF-R1, where they were examined for 80 samples of RF patients, and 40 healthy samples in the control group. The number of RF patients in Thi-Qar province showed a marked increase in the yearly rate of hemodialysis. A third of all patients had a considerable prevalence of RF linked to hypertension. The study concluded that a significant effect of TNF-α is associated with markers of kidney disease severity and distant organ dysfunction among patients with RF. In addition, this study found a correlation between the effects of TNF- α on end-stage renal disease. Extensive studies are needed to confirm these relationships.
References
Afkarin, Maryam, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. Jama, 2016, 316.6: 602-610.
Ghonemy, Tarek A., et al. Epidemiology and risk factors of chronic kidney disease in the El-Sharkia Governorate, Egypt. Saudi Journal of Kidney Diseases and Transplantation, 2016, 27.1: 111.
Humphreys, Benjamin D.; BONVENTRE, Joseph V. Mesenchymal stem cells in acute kidney injury. Annu. Rev. Med., 2008, 59: 311-325.
Singbartl, Kai; FORMECK, Cassandra L.; KELLUM, John A. Kidney-immune system crosstalk in AKI. In: Seminars in nephrology. WB Saunders, 2019. p. 96-106.
Parameswaran, Narayanan; PATIAL, Sonika. Tumor necrosis factor-α signaling in macrophages. Critical Reviews™ in Eukaryotic Gene Expression, 2010, 20.2.
Ramseyer, Vanesa D.; GARVIN, Jeffrey L. Tumor necrosis factor-α: regulation of renal function and blood pressure. American Journal of Physiology-Renal Physiology, 2013, 304.10: F1231-F1242.
Therrien, Frédérick J., et al. Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. American journal of nephrology, 2012, 36.2: 151-161.
Mehaffey, Eamonn P., et al. Intrarenal angiotensinogen production induced by chronic angiotensin II and high salt intake is augmented in tumor necrosis factor‐alpha receptor type 1 knockout mice. The FASEB Journal, 2016, 30: 1216.13-1216.13.
Castillo, Alexander, et al. Tumor necrosis factor-α receptor type 1, not type 2, mediates its acute responses in the kidney. American Journal of Physiology-Renal Physiology, 2012, 302.12: F1650-F1657.
Majid, Dewan SA. Tumor necrosis factor-α and kidney function: experimental findings in mice. In: Advances in TNF Family Research: Proceedings of the 12th International TNF Conference, 2009. New York, NY: Springer New York, 2010. p. 471-480.
Xun, Chunhua; ZHAO, Yong. Potential role of soluble TNF-α receptors in diagnosis of patients with chronic kidney disease. Annals of Clinical & Laboratory Science, 2017, 47.3: 310-314.
Niewczas, Monika A., et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. Journal of the American Society of Nephrology, 2012, 23.3: 507-515.
Amin, Noor, et al. Evaluating urea and creatinine levels in chronic renal failure pre and post dialysis: a prospective study. Journal of cardiovascular disease, 2014, 2.2: 1-4.
Doumas, Basil T.; WATSON, W. Ard; BIGGS, Homer G. Albumin standards and the measurement of serum albumin with bromcresol green. Clinica chimica acta, 1971, 31.1: 87-96.
Obesity, Weight Loss; RANGE, Number Sex Age. Clinical Research Protocol National Institute of Diabetes and Digestive and Kidney Diseases. 2017.
Poon, Richard KS. Chronic kidney disease in the elderly: assessment and management. Australian family physician, 2012, 41.12: 940-944.
Zeier, Martin; RITZ, Eberhard; RONCO, C. (ed.). Nephrology Grand Rounds. Clinical Issues in Nephrology. S. Karger, 1998.
Ahmed, Hussain Gadelkarim, et al. Etiology of chronic kidney disease (ckd) in Saudi Arabia. International Journal of Medical Research & Health Sciences, 2019, 8.5: 177-182.
Patney, Vikram; WHALEY-CONNELL, Adam; BAKRIS, George. Hypertension management in diabetic kidney disease. Diabetes Spectrum, 2015, 28.3: 175-180.
Wang, Xuening; XIAO, Shengxiang; XIA, Yumin. Tumor necrosis factor receptor mediates fibroblast growth factor-inducible 14 signaling. Cellular Physiology and Biochemistry, 2017, 43.2: 579-588.
Puch, Dan; GALLACHER, Peter J.; DHAUN, Neeraj. Management of hypertension in chronic kidney disease. Drugs, 2019, 79: 365-379.
Mosa, Azzam Abdulsattar. The Effect of Some Risk Factors Participating in the Incidence of Chronic Renal Failure. JOURNAL OF THI-QAR SCIENCE, 2011, 3.1.
Aljebory, Abdulhussien MK, et al. Effect of Kidney Dialysis on Some Biochemical Variance. In: Journal of Physics: Conference Series. IOP Publishing, 2019. p. 052019.
Sarhat, Entedhar Rifaat; MURTADHA, Nawal Abdullah. Biochemical changes in chronic renal failure pre and post hemodialysis. Journal of Environmental Science and Engineering A, 2016, 190.
Asif, Abuzar A.; HUSSAIN, Habiba; CHATTERJEE, Tulika. Extraordinary creatinine level: a case report. Cureus, 2020, 12.7.
Caravaca, Francisco, et al. Uraemic symptoms, nutritional status and renal function in pre‐dialysis end‐stage renal failure patients. Nephrology Dialysis Transplantation, 2001, 16.4: 776-782.
Rajendran, N. Biochemical evaluation of creatinine and urea in patients with
renal failure undergoing hemodialysis. Journal of Clinical Pathology and Laboratory
Medicine, .,(2017) ,1(2), 1–5.
Rule, Andrew D., et al. A comparison of serum creatinine–based methods for identifying chronic kidney disease in hypertensive individuals and their siblings. American journal of hypertension, 2006, 19.6: 608-614.
Farhan, L. Determanation of Several Biochemical Markers in Sera of Patients
with Kidney Diseases. Journal of Al-Nahrain University Science, .,(2013),16(3), 40–45.https://doi.org/10.22401/jnus.16.3.05
Tabrizi, Bahram Amouoghli; KARAROUDI, Meisam Naeimi. Evaluation of Serum Levels of AST, ALT, Total Bilirubin, FBC, Urea, and Creatinine After Administration of 99mTc-MIBI in Mice. American Journal of Clinical Pathology, 2012, 138.suppl_1: A016-A016.
Komatsu, Mizuki, et al. A low serum albumin level predicts cardiovascular events in hemodialysis patients with preserved left ventricular ejection fraction. International Journal of Clinical Medicine, 2015, 6.02: 85-95.
Mohammed, Doaa Jassim; Abd al-Rahman, owner of Juma'a; Money, shame Sami.. A comparative study of the effectiveness of some liver enzymes in chronic renal failure patients with hepatitis (C) and (B). Journal Tikrit Pure Sciences.2013, 54.
Delaney, Anthony P., et al. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Critical care medicine, 2011, 39.2: 386-391.
Demir, H., et al. Ischaemia-modified albumin elevation after percutaneous coronary intervention reflects albumin concentration rather than ischaemia. Annals of clinical biochemistry, 2009, 46.4: 327-331.
Tristyanto, Agung; SUROTO, Heri. The Clinical Function Comparison of Post Operative Nerve Grafting and Nerve Transfer in Patients with Brachial Plexus Injury. Indian Journal of Forensic Medicine & Toxicology, 2020, 14.2: 2013-2018.
Mimic-Oka, J.; Simic, T.; Pljesa, M.; Stupar, N.; and Turkovic, S. Oxidative Modifcations of Plasma Proteins in Different Stages of Chronic Renal Failure. Med. and Biol, (2001). 8. Pp : 1-5.
Jain, Ram B.; DUCATMAN, Alan. Perfluoroalkyl acids serum concentrations and their relationship to biomarkers of renal failure: Serum and urine albumin, creatinine, and albumin creatinine ratios across the spectrum of glomerular function among US adults. Environmental research, 2019, 174: 143-151.
Lang, Joshua, et al. Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders. Nephrology Dialysis Transplantation, 2018, 33.6: 986-992.
Molnar, Miklos Z., et al. High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients–. The American journal of clinical nutrition, 2011, 94.3: 945-954.
Lesaffer, Gerrit, et al. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. Nephrology Dialysis Transplantation, 2000, 15.1: 50-57.
Pallos, Debora, et al. Salivary markers in patients with chronic renal failure. Archives of oral biology, 2015, 60.12: 1784-1788.
Lee, So-Young; KIM, Sung I.; CHOI, Mary E. Therapeutic targets for treating fibrotic kidney diseases. Translational Research, 2015, 165.4: 512-530.
Idasiak-Piechocka, Ilona, et al. Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis. Nephrology Dialysis Transplantation, 2010, 25.12: 3948-3956.
Quiroga, Borja, et al. Present and future in the treatment of diabetic kidney disease. Journal of diabetes research, 2015, 2015.
Oh, Sung-Man, et al. Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times. BMC complementary and alternative medicine, 2017, 17.1: 1-9.
Mezil, Sabreen Ali; ALLAWI, Ali Abdulmajid Dyab; GHUDHAIB, Kadhim K. Determination of TNFR1 Level and its Association with ACR and eGFR in Iraqi Patients with Different Stages of Diabetic Nephropathy. Journal of Global Pharma Technology, 2018, 10.05: 449-454.
NIEWCZAS, Monika A., et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. Journal of the American Society of Nephrology, 2012, 23.3: 507-515.
Kumar, Ajay, et al. Effect of Drug therapy on transforming growth factor-β levels in end stage renal disease patients.
Pavkov, Meda E., et al. Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes. Kidney international, 2016, 89.1: 226-234.
Lv, Wenshan, et al. Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. European journal of pharmacology, 2018, 820: 65-76.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Z. Abdul Alamir Mezher
This work is licensed under a Creative Commons Attribution 4.0 International License.